Dr. Mary Meaghan P. Granger
Claim this profileCook Children's Medical Center
Studies Neuroblastoma
Studies Cancer
9 reported clinical trials
23 drugs studied
Area of expertise
1Neuroblastoma
MYC positive
Stage IV
MYC negative
2Cancer
Stage IV
SMARCB1 positive
SMARCA4 positive
Affiliated Hospitals
Clinical Trials Mary Meaghan P. Granger is currently running
Long-Term Follow-Up
for Cancer
This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep track of patients who have participated in Children's Oncology Group studies may allow doctors learn more about the long-term effects of cancer treatment and help them reduce problems related to treatment and improve patient quality of life.
Recruiting1 award N/A3 criteria
Lorlatinib + Standard Therapy
for Neuroblastoma
This phase III trial studies iobenguane I-131 or lorlatinib and standard therapy in treating younger patients with newly-diagnosed high-risk neuroblastoma or ganglioneuroblastoma. Radioactive drugs, such as iobenguane I-131, may carry radiation directly to tumor cells and not harm normal cells. Lorlatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving iobenguane I-131 or lorlatinib and standard therapy may work better compared to lorlatinib and standard therapy alone in treating younger patients with neuroblastoma or ganglioneuroblastoma.
Recruiting2 awards Phase 322 criteria
More about Mary Meaghan P. Granger
Clinical Trial Related4 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Mary Meaghan P. Granger has experience with
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
- Dinutuximab
- Temozolomide
- Quality-of-Life Assessment
- Iobenguane I-131
Breakdown of trials Mary Meaghan P. Granger has run
Neuroblastoma
Cancer
Ganglioneuroblastoma
Brain Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mary Meaghan P. Granger specialize in?
Mary Meaghan P. Granger focuses on Neuroblastoma and Cancer. In particular, much of their work with Neuroblastoma has involved MYC positive patients, or patients who are Stage IV.
Is Mary Meaghan P. Granger currently recruiting for clinical trials?
Yes, Mary Meaghan P. Granger is currently recruiting for 3 clinical trials in Fort Worth Texas. If you're interested in participating, you should apply.
Are there any treatments that Mary Meaghan P. Granger has studied deeply?
Yes, Mary Meaghan P. Granger has studied treatments such as Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis, Dinutuximab.
What is the best way to schedule an appointment with Mary Meaghan P. Granger?
Apply for one of the trials that Mary Meaghan P. Granger is conducting.
What is the office address of Mary Meaghan P. Granger?
The office of Mary Meaghan P. Granger is located at: Cook Children's Medical Center, Fort Worth, Texas 76104 United States. This is the address for their practice at the Cook Children's Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.